BioLongevity Labs provides AOD9604 for research purposes, sourced from USA GMP manufacturing facilities and verified by three levels of third-party testing
Injectable GHK-Cu carries more risk , particularly for copper accumulation, if you have underlying conditions affecting copper metabolism (like Wilsons disease or chronic liver disease)
At 10 mg/mL, here is what those markings translate to in tirzepatide: 1 unit = 0.1 mg tirzepatide 5 units = 0.5 mg tirzepatide 10 units = 1.0 mg tirzepatide 25 units = 2.5 mg tirzepatide 50 units = 5.0 mg tirzepatide 100 units = 10.0 mg tirzepatide This precision is why the 10 mg/mL concentration is universally recommended
You must not copy any of the materials
Localized injection (near the injury): May provide higher local peptide levels Often used for acute, localized injuries Inject within 23 inches of the injury site Can be combined with systemic injections Common in the first 12 weeks Systemic injection (abdominal): Provides whole-body distribution Suitable for multiple injuries or chronic conditions More convenient for long-term protocols Effective for internal organ healing Standard approach for general support Combined approach: Some protocols use both Example: a localized injection at the injury plus a systemic injection elsewhere May provide both local and systemic effects Requires higher total peptide amounts Storage and Handling Proper storage preserves potency and stability
Energy Levels One of the most noticeable benefits of MIC B12 injections is the increase in energy levels